ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,221,000 | -29.2% | 23,893 | -54.6% | 0.00% | -33.3% |
| Q3 2021 | $3,137,000 | +15.5% | 52,671 | +32.3% | 0.00% | 0.0% |
| Q2 2021 | $2,715,000 | -13.9% | 39,815 | -12.4% | 0.00% | 0.0% |
| Q1 2021 | $3,154,000 | -92.6% | 45,453 | -91.8% | 0.00% | -93.6% |
| Q4 2020 | $42,481,000 | +2.5% | 552,926 | -0.3% | 0.05% | -11.3% |
| Q3 2020 | $41,463,000 | +7.1% | 554,379 | -9.9% | 0.05% | +1.9% |
| Q2 2020 | $38,730,000 | -37.2% | 615,250 | -58.1% | 0.05% | 0.0% |
| Q1 2020 | $61,718,000 | +81.9% | 1,469,464 | +96.7% | 0.05% | +26.8% |
| Q4 2019 | $33,937,000 | -0.5% | 747,182 | +0.2% | 0.04% | -6.8% |
| Q3 2019 | $34,121,000 | -15.9% | 745,485 | +7.7% | 0.04% | -46.3% |
| Q2 2019 | $40,576,000 | +34.0% | 692,070 | +2.5% | 0.08% | +18.8% |
| Q1 2019 | $30,270,000 | – | 675,210 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |